Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
Merck
Baxter
Boehringer Ingelheim
Harvard Business School
AstraZeneca

Last Updated: May 28, 2022

Gd Searle Llc Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GD SEARLE LLC, and what generic and branded alternatives to GD SEARLE LLC drugs are available?

GD SEARLE LLC has twenty-seven approved drugs.



Summary for Gd Searle Llc
US Patents:0
Tradenames:25
Ingredients:16
NDAs:27

Drugs and US Patents for Gd Searle Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc POTASSIUM CHLORIDE potassium chloride INJECTABLE;INJECTION 086219-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Gd Searle Llc POTASSIUM CHLORIDE potassium chloride INJECTABLE;INJECTION 086220-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Gd Searle Llc ENOVID-E 21 mestranol; norethynodrel TABLET;ORAL-21 010976-007 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Gd Searle Llc AMMONIUM CHLORIDE ammonium chloride INJECTABLE;INJECTION 086205-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Gd Searle Llc DEMULEN 1/35-21 ethinyl estradiol; ethynodiol diacetate TABLET;ORAL-21 018168-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Gd Searle Llc ENOVID mestranol; norethynodrel TABLET;ORAL-20 010976-004 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Gd Searle Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 3,783,861 See Plans and Pricing
Gd Searle Llc CU-7 copper INTRAUTERINE DEVICE;INTRAUTERINE 017408-001 Approved Prior to Jan 1, 1982 3,803,308 See Plans and Pricing
Gd Searle Llc CU-7 copper INTRAUTERINE DEVICE;INTRAUTERINE 017408-001 Approved Prior to Jan 1, 1982 3,563,235 See Plans and Pricing
Gd Searle Llc TATUM-T copper INTRAUTERINE DEVICE;INTRAUTERINE 018205-001 Approved Prior to Jan 1, 1982 3,563,235 See Plans and Pricing
Gd Searle Llc CU-7 copper INTRAUTERINE DEVICE;INTRAUTERINE 017408-001 Approved Prior to Jan 1, 1982 RE28399 See Plans and Pricing
Gd Searle Llc DEMULEN 1/35-28 ethinyl estradiol; ethynodiol diacetate TABLET;ORAL-28 018160-001 Approved Prior to Jan 1, 1982 3,483,221 See Plans and Pricing
Gd Searle Llc CU-7 copper INTRAUTERINE DEVICE;INTRAUTERINE 017408-001 Approved Prior to Jan 1, 1982 4,040,417 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Merck
Baxter
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.